Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/16/2012WO2012109458A1 Flavin derivatives
08/16/2012WO2012109445A1 Hybrid opioid compounds and compositions
08/16/2012WO2012109423A1 Method of inhibiting hamartoma tumor cells
08/16/2012WO2012109415A1 Cathepsin c inhibitors
08/16/2012WO2012109406A1 Methods for treating pulmonary hypertension
08/16/2012WO2012109398A1 Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
08/16/2012WO2012109329A2 Methods for treatment of melanoma
08/16/2012WO2012109296A1 Antisense oligonucleotides
08/16/2012WO2012109292A1 Pesticidal compositions and processes related thereto
08/16/2012WO2012109263A1 Mannoside compounds and methods of use thereof
08/16/2012WO2012109238A2 Methods for increasing immune responses using agents that directly bind to and activate ire-1
08/16/2012WO2012109165A1 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
08/16/2012WO2012109164A1 Boron containing polybasic bacterial efflux pump inhibitors and therapeutics uses thereof
08/16/2012WO2012109152A1 Permeation enhancers for topical formulations
08/16/2012WO2012109108A1 S1p modulating agents
08/16/2012WO2012109100A1 Substituted benzimdazole derivatives useful as trpm8 receptor modulators
08/16/2012WO2012109080A1 Hepatitis c virus inhibitors
08/16/2012WO2012109075A1 Compounds and methods for kinase modulation, and indications therefor
08/16/2012WO2012109065A2 Treatment and prevention of cardiovascular disease and thrombosis
08/16/2012WO2012109011A1 SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
08/16/2012WO2012108841A1 Transglutaminase-2 inhibitors and uses thereof
08/16/2012WO2012108831A1 Metabotropic glutamate receptor group i antagonists for treatment of abnormal union of tissue
08/16/2012WO2012108794A2 1,2,4-triazol-3-ylthioglycolic acid derivatives for use in therapy
08/16/2012WO2012108738A2 Sildenafil-free base-containing film preparation and method for producing same
08/16/2012WO2012108689A2 Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor
08/16/2012WO2012108676A2 Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor
08/16/2012WO2012108631A2 Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof
08/16/2012WO2012108622A1 Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredient
08/16/2012WO2012108511A1 Pyrazole derivative and pest control agent
08/16/2012WO2012108490A1 Isoquinoline amide derivative
08/16/2012WO2012108489A1 Aqueous composition having improved hydrophilic drug penetrability
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012108397A1 Novel lipid
08/16/2012WO2012108379A1 Therapeutic agent for diastolic congestive heart failure
08/16/2012WO2012108376A1 Amino group-containing pyrrolidinone derivative
08/16/2012WO2012108347A1 Method for producing innate immunity activator having enhanced innate immunity promoting activity, and royal jelly-derived innate immunity activator which is produced by the production method
08/16/2012WO2012108297A1 AQUEOUS SOLUTION CONTAINING PARTIAL RaS POLYPEPTIDE AND METHOD FOR SCREENING INHIBITOR OF RaS FUNCTION
08/16/2012WO2012108266A1 Orally disintegrating tablet and production method therefor
08/16/2012WO2012107905A1 Composition for use in the treatment of menopause problems/disorders and in the treatment of general aging of the organism.
08/16/2012WO2012107769A1 Treatment of allergic disorders
08/16/2012WO2012107724A1 Mir-30 for use in the modulation of angiogenesis
08/16/2012WO2012107708A1 Administration regime for nitrocatechols
08/16/2012WO2012107706A1 Phenothiazine diaminium salts and their use
08/16/2012WO2012107652A1 Effervescent gamma-hydroxybutyric acid granules
08/16/2012WO2012107585A1 Novel concentrated and stable topical antiparasitic compositions
08/16/2012WO2012107565A1 Novel antifungal composition
08/16/2012WO2012107541A1 Pharmaceutical composition comprising tadalafil and a cyclodextrin
08/16/2012WO2012107532A1 4-aminoalcoholquinoline derivatives, enantioselective synthesis methods and the use thereof
08/16/2012WO2012107531A1 B-type plexin antagonists and uses thereof
08/16/2012WO2012107500A1 [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
08/16/2012WO2012107499A1 Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
08/16/2012WO2012107498A1 Lysine demethylase inhibitors for myeloproliferative disorders
08/16/2012WO2012107476A1 Pharmaceutical composition, methods for treating and uses thereof
08/16/2012WO2012107455A1 Galactofructose for the regulatory effect thereof on intestinal transit
08/16/2012WO2012107402A1 Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events
08/16/2012WO2012107390A1 Antimicrobial composition
08/16/2012WO2012107371A1 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/16/2012WO2012107364A1 Novel composition for the treatment of cystic fibrosis
08/16/2012WO2012107363A1 Novel composition for the treatment of cystic fibrosis
08/16/2012WO2012107356A1 Aqueous pharmaceutical composition for preventing and/or treating allergically irritated nasal mucosa and use thereof
08/16/2012WO2012107304A1 Histone deacetylase (hdac) inhibiting compounds and method of making same
08/16/2012WO2012107262A1 Dihydrobenzopyran, thiochroman, tetrahydroquinoleine and tetrahydronaphtalene derivatives and their use in anticancer therapy
08/16/2012WO2012107093A1 Storage-stable formulation of paracetamol in aqueous solution
08/16/2012WO2012107092A1 Pharmaceutical composition comprising tadalafil and a cyclodextrin
08/16/2012WO2012107090A1 Granulated composition comprising tadalafil and a disintegrant
08/16/2012WO2012106995A1 Rorgammat inhibitors
08/16/2012WO2012106947A1 Medicine composition containing vitamin d and metformin
08/16/2012WO2012106812A1 A method of treating cancer
08/16/2012WO2012091357A3 Composition for prevention of nausea or vomiting
08/16/2012WO2012088266A3 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/16/2012WO2012088124A3 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
08/16/2012WO2012087255A3 Pharmaceutical formulations comprising imatinib
08/16/2012WO2012087047A3 Percutaneous absorption preparation containing rivastigmine
08/16/2012WO2012084164A3 Antimicrobial composition having skin care properties
08/16/2012WO2012082013A3 Pharmaceutical composition for stimulating the regeneration of supporting tissue and articular cartilage (variants)
08/16/2012WO2012081893A3 Novel 3-indolinone derivative and composition having same
08/16/2012WO2012080984A3 Controlled-release pharmaceutical tablet for oral administration
08/16/2012WO2012080466A3 Ingenols for treating seborrheic keratosis
08/16/2012WO2012079721A8 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
08/16/2012WO2012078746A9 Compositions and methods for mobilizing stem cells
08/16/2012WO2012078667A9 Compositions and methods relating to proliferative diseases
08/16/2012WO2012078574A9 Janus kinase 2 (jak2) inhibitor for the treatment of lupus
08/16/2012WO2012076756A3 Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans
08/16/2012WO2012075443A9 Methods for delivering clonidine compositions in a biodegradable polymer carrier and local steriods to a target tissue site
08/16/2012WO2012075383A3 Bromodomain inhibitors and uses thereof
08/16/2012WO2012075379A3 Liquid viral formulations
08/16/2012WO2012075376A3 Lyophilized viral formulations
08/16/2012WO2012075211A3 Combination therapy with a gallium complex
08/16/2012WO2012075081A3 High-strength testosterone undecanoate compositions
08/16/2012WO2012074676A3 Glp-1 agonists, dpp-4 inhibitors, compositions, and uses related thereto
08/16/2012WO2012072977A3 Formulations comprising methylthionium chloride
08/16/2012WO2012071414A3 Quinoxaline compounds and uses thereof
08/16/2012WO2012071324A3 Pharmaceutical compositions
08/16/2012WO2012071096A3 Arid1a and ppp2r1a mutations in cancer
08/16/2012WO2012070071A9 Compounds and their use
08/16/2012WO2012069150A3 Cytoprotectant agents for the prevention of drug-associated side-effects
08/16/2012WO2012068456A3 Compositions and methods for treating obesity
08/16/2012WO2012068441A3 Intedanib salts and solid state forms thereof
08/16/2012WO2012068106A3 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
08/16/2012WO2012068038A3 Caffeic acid derivatives and their use in improving neuronal cell viability
1 ... 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 ... 7860